Details for New Drug Application (NDA): 210180
✉ Email this page to a colleague
The generic ingredient in APIXABAN is apixaban. There are thirty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the apixaban profile page.
Summary for 210180
Tradename: | APIXABAN |
Applicant: | Accord Hlthcare |
Ingredient: | apixaban |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Jul 28, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jul 28, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription